Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

NCT05218356 is registered in ClinicalTrials.gov with Code Pharma as lead sponsor.

NCT NCT05218356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05218356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19
Lead sponsor
Code Pharma
Phase
Phase 2
Overall status
Recruiting
Start date
January 20, 2022
Completion date
July 20, 2025
Enrollment
130 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19